已收录 270542 条政策
 政策提纲
  • 暂无提纲
Inhibitory Effect of a Novel Antianginal Agent, E4080, on ST Segment Elevation Induced by Vasopressin in Anesthetized Guinea Pigs
[摘要] References(21)Cited-By(4)We compared the antianginal effect of E4080, a novel bradycardic agent with coronary vasodilating properties, with those of a bradycardic agent and some coronary vasodilators in vasopressin-induced anginal model of guinea pigs. An i.v.-administration of vasopressin (0.2IU/kg) produced an ST segment elevation on electrocardiograms (ECG) of 0.30 ± 0.05 mV from the baseline within 30 sec in anesthetized guinea pigs. The ST segment elevation on ECG was used as an index of myocardial ischemia. E4080 and other drugs were injected i.v. 5 min before the administration of vasopressin. E4080 at 5 mg/kg depressed the ST segment elevation induced by vasopressin to 0.06 ± 0.01 mV (20% of control, n = 6, P < 0.001). However, alinidine (5 mg/kg), which produced the same bradycardic action (reduction of heart rate by 50%) as that of E4080, tended to inhibit the ST segment elevation, but this was not statistically significant. On the other hand, other vasodilators such as isosorbide dinitrate (0.3 mg/kg), nifedipine (0.1 mg/kg) and lemakalim (1 mg/kg) also significantly reduced the ST segment elevation to 0.16 ± 0.03, 0.08 ± 0.04 and 0.09 ± 0.03 mV, respectively. These results suggest that the inhibitory effect of E4080 on the ST segment elevation induced by vasopressin is due to the coronary vasodilating effect rather than the bradycardic effect, and that E4080 would be useful as an antianginal agent.
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 药理学
[关键词] E4080;Bradycardic agent;Coronary vasodilator;Vasopressin;ST segment elevation [时效性] 
   浏览次数:10      统一登录查看全文      激活码登录查看全文